Emerson Schedules First Quarter 2026 Earnings Release and Conference Call

Emerson (NYSE: EMR) will report its first quarter results after market close on Tuesday, February 3, 2026. Emerson senior management will discuss the results during an investor conference call that same day, beginning at 4:30 p.m. Eastern Time, 3:30 p.m. Central Time. All interested parties may listen to the live conference call and view presentation […]

Charter Closes $3.0 Billion Senior Unsecured Notes

Charter Communications, Inc. (NASDAQ: CHTR) (along with its subsidiaries, “Charter”) today announced that its subsidiaries, CCO Holdings, LLC (“CCO Holdings”) and CCO Holdings Capital Corp. (“CCO Holdings Capital,” and together with CCO Holdings, the “Issuers”), have closed on $3.0 billion in aggregate principal amount of senior unsecured notes consisting of the following securities: — $1.75

Lear Announces Date for Fourth Quarter and Full Year 2025 Earnings Conference Call

Lear Corporation will hold a conference call to review the company’s fourth quarter and full year 2025 financial results and related matters on February 4, 2026, at 9:00 a.m. EST. To participate in the conference call: — Webcast link: click here — Toll-free calls: 877-883-0383 — International calls: 412-902-6506 The conference code is 0809356. You

UniFirst Declares Regular Cash Dividends

(NYSE:UNF), WILMINGTON, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) — The Board of Directors of UniFirst Corporation (NYSE:UNF) today declared regular quarterly cash dividends of $0.365 per share (36.5 cents) on the Company's Common Stock and $0.292 per share (29.2 cents) on the Company's Class B Common Stock. Both dividends are payable on March 27, 2026

South Plains Financial, Inc. Announces Fourth Quarter 2025 Earnings Call

(NASDAQ:SPFI), LUBBOCK, Texas, Jan. 13, 2026 (GLOBE NEWSWIRE) — South Plains Financial, Inc. (NASDAQ:SPFI) (“South Plains” or the “Company”), the parent company of City Bank, today announced that its fourth quarter 2025 financial results will be released after market close on Monday, January 26, 2026. The Company will host a conference call and webcast at

INVO Fertility to Participate in the Lytham Partners 2026 Investor Healthcare Summit on January 15, 2026

(NASDAQ:IVF), SARASOTA, Fla., Jan. 13, 2026 (GLOBE NEWSWIRE) — INVO Fertility, Inc. (Nasdaq: IVF) (“INVO” or the “Company”), a healthcare fertility company focused on the establishment, acquisition, and operation of fertility clinics and related businesses and technologies, today announced that it will participate in a webcast fireside chat at the Lytham Partners 2026 Investor Healthcare

Solid Biosciences Provides 2026 Outlook Underscoring Neuromuscular and Cardiac Pipeline Momentum and Expanded Access to Next-Generation Capsid AAV-SLB101

(NASDAQ:SLDB), – Duchenne: Dosed 33 participants in the Phase 1/2 INSPIRE DUCHENNE clinical trial as of January 9, 2026; SGT-003 continues to be generally well tolerated using a steroid-only prophylactic immunomodulation regimen – – Duchenne: First participant enrolled in IMPACT DUCHENNE, a Phase 3 randomized, double-blind, placebo-controlled, ex-U.S. clinical trial, with dosing expected in Q1

Mercury Systems to Report Second Quarter Fiscal Year 2026 Financial Results on February 3, 2026

(NASDAQ:MRCY), ANDOVER, Mass., Jan. 13, 2026 (GLOBE NEWSWIRE) — Mercury Systems Inc. (NASDAQ: MRCY, www.mrcy.com), a global technology company that delivers mission-critical processing to the edge, will release its second quarter fiscal year 2026 financial results after the market close on Tuesday, February 3, 2026. Management will host a conference call and simultaneous webcast at

O-I Glass Announces Full Year and Fourth Quarter 2025 Earnings Conference Call and Webcast

(NYSE:OI), PERRYSBURG, Ohio, Jan. 13, 2026 (GLOBE NEWSWIRE) — O-I Glass, Inc. (NYSE: OI) has scheduled its full year and fourth quarter 2025 conference call and webcast for Wednesday, February 11, 2026, at 8 a.m. EST. The Company's news release for the full year and fourth quarter 2025 earnings will be issued after the market

Rapid Micro Biosystems Announces Record Preliminary Unaudited Fourth Quarter and Full Year 2025 Revenue

(NASDAQ:RPID), Fourth quarter 2025 total revenue expected to be approximately $11.3 million, representing growth of approximately 37% compared to the prior-year period. Received record multi-system order in the fourth quarter from an existing Top 20 global biopharma customer to automate global manufacturing network. Full year 2025 total revenue expected to be approximately $33.6 million, representing

Scroll to Top